Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-125177
Filing Date
2022-04-28
Accepted
2022-04-28 06:22:08
Documents
18
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d213583d10ka.htm   iXBRL 10-K/A 398669
2 EX-31.1 d213583dex311.htm EX-31.1 12506
3 EX-31.2 d213583dex312.htm EX-31.2 12594
4 EX-32.1 d213583dex321.htm EX-32.1 4236
5 EX-32.2 d213583dex322.htm EX-32.2 3699
  Complete submission text file 0001193125-22-125177.txt   720374

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crxt-20211231.xsd EX-101.SCH 4709
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crxt-20211231_cal.xml EX-101.CAL 693
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crxt-20211231_def.xml EX-101.DEF 19995
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crxt-20211231_lab.xml EX-101.LAB 25331
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crxt-20211231_pre.xml EX-101.PRE 21334
12 EXTRACTED XBRL INSTANCE DOCUMENT d213583d10ka_htm.xml XML 9436
Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

EIN.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39802 | Film No.: 22862036
SIC: 2836 Biological Products, (No Diagnostic Substances)